Fennec Historical Income Statement
| FENC Stock | USD 9.09 0.09 0.98% |
Historical analysis of Fennec Pharmaceuticals income statement accounts such as Interest Expense of 3.6 M or Selling General Administrative of 21.6 M can show how well Fennec Pharmaceuticals performed in making a profits. Evaluating Fennec Pharmaceuticals income statement over time to spot trends is a great complementary tool to traditional technical analysis and can indicate the direction of Fennec Pharmaceuticals's future profits or losses.
Financial Statement Analysis is much more than just reviewing and examining Fennec Pharmaceuticals latest accounting reports to predict its past. Macroaxis encourages investors to analyze financial statements over time for various trends across multiple indicators and accounts to determine whether Fennec Pharmaceuticals is a good buy for the upcoming year.
Fennec |
About Fennec Income Statement Analysis
Fennec Pharmaceuticals Income Statement consists of revenues and expenses along with the resulting net income or loss. It represents the profit for the accounting period attributable to Fennec Pharmaceuticals shareholders. The income statement also shows Fennec investors and management if the firm made money during the period reported. The result of an income statement is the net income that is calculated after subtracting the expenses from revenue. It is essential to investors both as an absolute measure as well as earnings per share (i.e., EPS).
Fennec Pharmaceuticals Income Statement Chart
Fennec Pharmaceuticals Income Statement is one of the three primary financial statements used for reporting Fennec's overall financial performance over a current year or for a given accounting period. An Income Statement sometimes referred to as the statement of Fennec Pharmaceuticals revenue and expense. Fennec Pharmaceuticals Income Statement primarily focuses on the company's revenues and expenses during a particular period.
At present, Fennec Pharmaceuticals' Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 21.6 M, whereas Operating Income is forecasted to decline to (13.7 M). Add Fundamental
Other Operating Expenses
Other Operating Expenses is the expense which generally does not depend on sales or production quantities of Fennec Pharmaceuticals. It is also known as Fennec Pharmaceuticals overhead expenses. Typically these expenses include marketing, rent and utilities, office, leases, and other overhead cost. Expenses incurred from non-core business activities, including administrative and general expenses, but excluding costs directly related to production.Total Operating Expenses
The total costs associated with the day-to-day operations of a business, excluding the cost of goods sold but including selling, general, and administrative expenses.Most accounts from Fennec Pharmaceuticals' income statement are interrelated and interconnected. However, analyzing income statement accounts one by one will only give a small insight into Fennec Pharmaceuticals current financial condition. On the other hand, looking into the entire matrix of income statement accounts, and analyzing their relationships over time can provide a more complete picture of the company financial strength now and in the future. Check out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fennec Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.At present, Fennec Pharmaceuticals' Interest Expense is projected to increase significantly based on the last few years of reporting. The current year's Selling General Administrative is expected to grow to about 21.6 M, whereas Operating Income is forecasted to decline to (13.7 M).
Fennec Pharmaceuticals income statement Correlations
Click cells to compare fundamentals
Fennec Pharmaceuticals Account Relationship Matchups
High Positive Relationship
High Negative Relationship
Fennec Pharmaceuticals income statement Accounts
| 2019 | 2020 | 2021 | 2022 | 2023 | 2024 (projected) | ||
| Depreciation And Amortization | 64K | (100K) | 38K | 46K | 287K | 436.6K | |
| Selling General Administrative | 7.4M | 13.0M | 12.2M | 17.7M | 20.6M | 21.6M | |
| Other Operating Expenses | 13.0M | 18.1M | 17.2M | 24.1M | 34.6M | 36.4M | |
| Operating Income | (13.0M) | (17.9M) | (17.2M) | (22.6M) | (13.0M) | (13.7M) | |
| Net Income From Continuing Ops | (12.8M) | (18.1M) | (17.3M) | (23.7M) | (20.2M) | (19.2M) | |
| Ebit | (13.0M) | (17.9M) | (17.2M) | (22.6M) | (13.3M) | (14.0M) | |
| Research Development | 5.6M | 5.1M | 5.0M | 3.5M | 57.0K | 54.2K | |
| Ebitda | (12.9M) | (18.0M) | (17.2M) | (22.5M) | (13.0M) | (13.7M) | |
| Total Operating Expenses | 13.0M | 18.1M | 17.2M | 24.0M | 33.4M | 35.0M | |
| Income Before Tax | (12.8M) | (18.1M) | (17.3M) | (23.7M) | (16.3M) | (15.5M) | |
| Total Other Income Expense Net | 234K | (224K) | (123K) | (1.1M) | (3.3M) | (3.2M) | |
| Net Income Applicable To Common Shares | (12.8M) | (18.1M) | (17.3M) | (23.7M) | (21.3M) | (20.3M) | |
| Net Income | (12.5M) | (17.9M) | (17.5M) | (24.8M) | (16.3M) | (15.5M) | |
| Income Tax Expense | (315K) | (187K) | 110K | 1.1M | 1.0 | 0.95 | |
| Non Operating Income Net Other | 521K | 234K | (224K) | (123K) | (110.7K) | (105.2K) | |
| Net Interest Income | 251K | (315K) | (72K) | (932K) | (2.9M) | (2.7M) |
Some investors attempt to determine whether the market's mood is bullish or bearish by monitoring changes in market sentiment. Unlike more traditional methods such as technical analysis, investor sentiment usually refers to the aggregate attitude towards Fennec Pharmaceuticals in the overall investment community. So, suppose investors can accurately measure the market's sentiment. In that case, they can use it for their benefit. For example, some tools to gauge market sentiment could be utilized using contrarian indexes, Fennec Pharmaceuticals' short interest history, or implied volatility extrapolated from Fennec Pharmaceuticals options trading.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectCheck out Investing Opportunities to better understand how to build diversified portfolios, which includes a position in Fennec Pharmaceuticals. Also, note that the market value of any company could be tightly coupled with the direction of predictive economic indicators such as signals in board of governors. For information on how to trade Fennec Stock refer to our How to Trade Fennec Stock guide.You can also try the Headlines Timeline module to stay connected to all market stories and filter out noise. Drill down to analyze hype elasticity.
Complementary Tools for Fennec Stock analysis
When running Fennec Pharmaceuticals' price analysis, check to measure Fennec Pharmaceuticals' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Fennec Pharmaceuticals is operating at the current time. Most of Fennec Pharmaceuticals' value examination focuses on studying past and present price action to predict the probability of Fennec Pharmaceuticals' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Fennec Pharmaceuticals' price. Additionally, you may evaluate how the addition of Fennec Pharmaceuticals to your portfolios can decrease your overall portfolio volatility.
| Options Analysis Analyze and evaluate options and option chains as a potential hedge for your portfolios | |
| Bollinger Bands Use Bollinger Bands indicator to analyze target price for a given investing horizon | |
| Idea Breakdown Analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes | |
| Stock Tickers Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites | |
| Transaction History View history of all your transactions and understand their impact on performance | |
| Watchlist Optimization Optimize watchlists to build efficient portfolios or rebalance existing positions based on the mean-variance optimization algorithm | |
| ETF Categories List of ETF categories grouped based on various criteria, such as the investment strategy or type of investments |
Is Fennec Pharmaceuticals' industry expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Fennec Pharmaceuticals. If investors know Fennec will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Fennec Pharmaceuticals listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (0.60) | Revenue Per Share 0.8 | Quarterly Revenue Growth 5.342 | Return On Assets (0.30) | Return On Equity (10.06) |
The market value of Fennec Pharmaceuticals is measured differently than its book value, which is the value of Fennec that is recorded on the company's balance sheet. Investors also form their own opinion of Fennec Pharmaceuticals' value that differs from its market value or its book value, called intrinsic value, which is Fennec Pharmaceuticals' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Fennec Pharmaceuticals' market value can be influenced by many factors that don't directly affect Fennec Pharmaceuticals' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Fennec Pharmaceuticals' value and its price as these two are different measures arrived at by different means. Investors typically determine if Fennec Pharmaceuticals is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Fennec Pharmaceuticals' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.